Severe Congenital Myopathy and Neuropathy with Congenital Cataracts due to GFER Variant: A Neuropathological Study

Abstract

We describe the clinical, muscle and nerve biopsy, and genetic findings in a 10-year-old girl with a profound and rapid global regression. She presented during neonatal period with hypotonia, followed by weakness in the facial, bulbar, respiratory, and neck flexor muscles. She developed bilateral cataracts at 4 months of age and started to regress. Quadriceps muscle biopsy revealed extensive fiber atrophy but sparing of some, predominantly type 1, fibers. Sural nerve biopsy showed depletion of myelinated and unmyelinated fibers; most remaining myelinated fibers were of small caliber. Neuroimaging revealed global brain atrophy. Although the investigations indicated a multisystem disorder, extensive genetic and metabolic investigations were negative. She was tracheostomy- and ventilator-dependent for most of her life. The child died at 10 years of age. Further deoxyribonucleic acid analysis undertaken via whole genome sequencing revealed a novel pathogenic GFER sequence variant consistent with the patient's clinical presentation.

Keywords

GFER - congenital myopathy - congenital neuropathy - cataracts - developmental delay

Ethical Publication Statement

We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

Publication History

Received: 01 February 2022

Accepted: 20 April 2022

Article published online:
20 June 2022

• References

• 1 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 2 Ellard S, Baple EL, Callaway A. , et al. ACGS Best Practice Guidelines for Variant Classification in Rare Disease 2020. Association for Clinical Genomic Science. Accessed May 3, 2022 at: https://www.acgs.uk.com/media/11631/uk-practice-guidelines-for-variant-classification-v4-01-2020.pdf
• 3 Giorda R, Hagiya M, Seki T. et al. Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med 1996; 2 (01) 97-108
• 4 Di Fonzo A, Ronchi D, Lodi T. et al. The mitochondrial disulfide relay system protein GFER is mutated in autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency. Am J Hum Genet 2009; 84 (05) 594-604
• 5 Rouault TA, Tong WH. Iron-sulfur cluster biogenesis and human disease. Trends Genet 2008; 24 (08) 398-407
• 6 Stehling O, Wilbrecht C, Lill R. Mitochondrial iron-sulfur protein biogenesis and human disease. Biochimie 2014; 100: 61-77
• 7 Tury A, Mairet-Coello G, Lisowsky T, Griffond B, Fellmann D. Expression of the sulfhydryl oxidase ALR (Augmenter of Liver Regeneration) in adult rat brain. Brain Res 2005; 1048 (1-2): 87-97
• 8 Di Rosa G, Deodato F, Loupatty FJ. et al. Hypertrophic cardiomyopathy, cataract, developmental delay, lactic acidosis: a novel subtype of 3-methylglutaconic aciduria. J Inherit Metab Dis 2006; 29 (04) 546-550
• 9 Calderwood L, Holm IA, Teot LA, Anselm I. Adrenal insufficiency in mitochondrial disease: a rare case of GFER-related mitochondrial encephalomyopathy and review of the literature. J Child Neurol 2016; 31 (02) 190-194
• 10 North K, Korson MS, Krawiecki N, Shoffner JM, Holm IA. Oxidative phosphorylation defect associated with primary adrenal insufficiency. J Pediatr 1996; 128 (5 Pt 1): 688-692
• 11 Thevenon J, Duffourd Y, Masurel-Paulet A. et al. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test. Clin Genet 2016; 89 (06) 700-707
• 12 Nambot S, Gavrilov D, Thevenon J. et al. Further delineation of a rare recessive encephalomyopathy linked to mutations in GFER thanks to data sharing of whole exome sequencing data. Clin Genet 2017; 92 (02) 188-198
• 13 Yang Y, Muzny DM, Xia F. et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 2014; 312 (18) 1870-1879
• 14 Martikainen MH, Grady JP, Ng YS. et al. Decreased male reproductive success in association with mitochondrial dysfunction. Eur J Hum Genet 2017; 25 (10) 1162-1164
• 15 Angelicheva D, Turnev I, Dye D, Chandler D, Thomas PK, Kalaydjieva L. Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome: a novel developmental disorder in Gypsies maps to 18qter. Eur J Hum Genet 1999; 7 (05) 560-566
• 16 Varon R, Gooding R, Steglich C. et al. Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome. Nat Genet 2003; 35 (02) 185-189
• 17 Kalaydjieva L. Congenital cataracts-facial dysmorphism-neuropathy. Orphanet J Rare Dis 2006; 1: 32
• 18 Merlini L, Gooding R, Lochmüller H. et al. Genetic identity of Marinesco-Sjögren/myoglobinuria and CCFDN syndromes. Neurology 2002; 58 (02) 231-236